IMGT (XKRX:456570) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is IMGT ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IMGT's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

IMGT ROCE % Historical Data

The historical data trend for IMGT's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT ROCE % Chart

IMGT Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

IMGT Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
ROCE %	-	-	-	-

IMGT ROCE % Calculation

IMGT's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6403.395	/	( ( (15268.042 - 41454.268)	+	(10559.766 - 26360.544) )	/ 2 )
	=	6403.395	/	( (-26186.226	+	-15800.778)	/ 2 )
	=	6403.395	/	-20993.502
	=	-30.50 %

IMGT's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	6403.395	/	( ( (15268.042 - 41454.268)	+	(10559.766 - 26360.544) )	/ 2 )
	=	6403.395	/	( ( -26186.226	+	-15800.778 )	/ 2 )
	=	6403.395	/	-20993.502
	=	0 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

IMGT (XKRX:456570) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IMGT ROCE % Related Terms

Thank you for viewing the detailed overview of IMGT's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605

Website

http://www.imgt.co.kr

IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines